Sanuwave Health Inc (SNWV) 13F Filing Data & Analysis (Q2 2026)

SNWV ranks #6124 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

51 institutions disclose a position in SNWV, but none treat it as a major bet — even Solas Capital Management, LLC, its most concentrated holder, allocates just 3.3% of its own portfolio to it.

BNP Paribas Financial Markets has added to its SNWV position for two straight quarters, increasing it by $132.6K to reach $133.0K today.

Opaleye Management Inc. has trimmed its SNWV position for two straight quarters, cutting it by $26.2M while still holding $3.1M.

SNWV is up 4.3% today, but institutions show net selling of $5.7M this quarter — a divergence between today's price move and the underlying institutional flow.

SNWV posted net income of $13.7M over the trailing twelve months, and currently trades at a P/E of 3.2.

• Profitable — net income of $13.7M over the trailing twelve months
• Revenue grew 11.9% year over year
• Net income improved year over year, from -$41.2M to $13.7M
• Generated $3.9M in positive operating cash flow
• Current ratio of 1.38x — below the conventional 1.5x liquidity buffer
• Liabilities run 22.07x equity — a highly leveraged balance sheet worth noting